DCP, Sequoia China lead Series B round for medical devices firm Valgen

DCP, Sequoia China lead Series B round for medical devices firm Valgen

Source: Valgen Medtech

Greater China-focused private equity firm DCP and tech investment bellwether Sequoia Capital China have co-led a Series B round of financing for Valgen Medtech, a developer of treatment technologies for heart diseases in China. The investment size is said to be “hundreds of millions of US dollars.”

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter